Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis
12 of 32 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Arthritis & rheumatology (Hoboken, N.J.)
- Published
- Topic
- Clinical care
- Subject terms
- Skin; Humans; Scleroderma, Systemic; Scleroderma, Diffuse; Treatment Outcome; Severity of Illness Index; Cannabinoid Receptor Agonists; Dronabinol
- PubMed ID
- 37098795
- Added to directory
- Source checked